SpliSense Revenue and Competitors
Estimated Revenue & Valuation
- SpliSense's total funding is $43M.
Employee Data
- SpliSense has 15 Employees.
- SpliSense grew their employee count by -6% last year.
SpliSense's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CSO and Scientific Founder | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | VP CMC | Reveal Email/Phone |
5 | VP, Research | Reveal Email/Phone |
6 | Director Clinical and Regulatory Affairs | Reveal Email/Phone |
7 | Senior Researcher | Reveal Email/Phone |
8 | CBO | Reveal Email/Phone |
9 | Research Assistant | Reveal Email/Phone |
SpliSense Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 23 | 53% | N/A | N/A |
#2 | N/A | 49 | 40% | $22M | N/A |
#3 | N/A | 32 | 7% | $23.4M | N/A |
#4 | N/A | 15 | -6% | $43M | N/A |
#5 | N/A | 43 | 26% | $12.5M | N/A |
#6 | N/A | 28 | 0% | N/A | N/A |
#7 | N/A | 24 | 9% | $16.1M | N/A |
#8 | N/A | 8 | 0% | N/A | N/A |
#9 | N/A | 19 | 6% | $8.44M | N/A |
#10 | N/A | 4 | 0% | N/A | N/A |
What Is SpliSense?
SpliSense Ltd., is a growing and exciting biotechnology company, developing novel therapies for genetic diseases by inhalation. The company is currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients.
keywords:N/A$43M
Total Funding
15
Number of Employees
N/A
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | -32% | N/A |
#2 | N/A | 15 | N/A | N/A |
#3 | $4.2M | 15 | 0% | $12M |
#4 | $4.9M | 15 | -25% | N/A |
#5 | $5.3M | 17 | 0% | N/A |